[1]蔡敏一,赵德强,于宏梅,等.老年冠心病患者血清脂联素、生长素释放肽水平与血小板聚集率及主要不良心脏事件相关性分析[J].陕西医学杂志,2024,(7):931-935.[doi:DOI:10.3969/j.issn.1000-7377.2024.07.014]
　CAI Minyi,ZHAO Deqiang,YU Hongmei,et al.Correlation analysis of serum APN and Ghrelin levels with platelet aggregation rate and major adverse cardiac events in elderly patients with coronary heart disease[J].,2024,(7):931-935.[doi:DOI:10.3969/j.issn.1000-7377.2024.07.014]
点击复制

老年冠心病患者血清脂联素、生长素释放肽水平与血小板聚集率及主要不良心脏事件相关性分析
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年7期
页码:
931-935
栏目:
临床研究
出版日期:
2024-07-05

文章信息/Info

Title:
Correlation analysis of serum APN and Ghrelin levels with platelet aggregation rate and major adverse cardiac events in elderly patients with coronary heart disease
作者:
蔡敏一1; 赵德强1; 于宏梅1; 高海超2; 汪蔚青1
(1.上海中医药大学附属普陀医院离休干部科,上海 200062; 2承德医学院附属医院心内科,河北 承德 067000)
Author(s):
CAI Minyi; ZHAO Deqiang; YU Hongmei; GAO Haichao; WANG Weiqing
(Department of Senior Staff,Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 200062,China)
关键词:
冠心病;  脂联素;  生长素释放肽;  血小板聚集率;  主要不良心脏事件;  相关性
Keywords:
Coronary heart disease;  APN;  Ghrelin;  Platelet aggregation rate;  Major adverse cardiac events;  Correlation
分类号:
R 541.4
DOI:
DOI:10.3969/j.issn.1000-7377.2024.07.014
文献标志码:
A
摘要:
目的:探讨老年冠心病(CHD)患者血清脂联素(APN)、生长素释放肽(Ghrelin)水平与血小板聚集率(PAG)及主要心脏不良事件(MACE)之间的相关性。方法:选择83例老年CHD患者为病例组,另收集同期72例健康体检者作为对照组。入院后收集所有受试者一般资料,并检测其空腹血糖、血脂等生化指标。酶联免疫吸附法检测血清APN、Ghrelin水平。采用血小板聚集仪比浊法测定PAG,分析其与血清APN、Ghrelin水平之间的相关性。出院后随访12周,记录患者MACE发生情况,分析血清APN、Ghrelin水平与MACE之间的相关性。结果:CHD组与对照组总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、血尿酸(UA)、左心室舒张末期内径(LVEDD)及左心室射血分数(LVEF)等水平比较,差异有统计学意义(均P<0.05)。与对照组比较,CHD组APN与Ghrelin水平明显降低(均P<0.05)。与对照组比较,CHD组PAG显著增加(均P<0.05)。Pearson相关性分析显示,CHD患者血清APN、Ghrelin水平与PAG呈明显负相关(r=-0.792,-0.578,均P<0.05)。83例CHD患者有26例发生MACE,与未发生MACE患者比较,两组HDL、LVEDD、LVEF、APN及Ghrelin水平比较差异有统计学意义(均P<0.05)。Logistic回归分析显示,HDL、LVEF、APN、Ghrelin是MACE发生的保护因素(均P<0.05)。结论:老年CHD患者血清APN、Ghrelin水平显著降低,且与血小板聚集率及预后有着密切关系,低水平APN、Ghrelin可一定程度上反映CHD患者MACE的发生风险。
Abstract:
Objective:To investigate the correlation between serum adiponectin(APN),Ghrelin levels,platelet aggregation rate(PAG)and major adverse cardiac events(MACE)in elderly patients with coronary heart disease(CHD).Methods:A total of 83 elderly patients with CHD were selected as the case group,and 72 healthy subjects were selected as the control group.After admission,the general data of all subjects were collected,and their fasting blood glucose,blood lipid and other biochemical indicators were detected.Serum APN and Ghrelin levels were detected by enzyme-linked immunosorbent assay.The correlation between PAG and serum APN、Ghrelin levels was analyzed by turbidimetry with platelet aggregator.The patients were followed up for 12 weeks after discharge,the occurrence of MACE was recorded,and the correlation between serum APN、Ghrelin level and MACE was analyzed.Results:There were significant differences in total cholesterol(TC),triglyceride(TG),high density lipoprotein(HDL),low density lipoprotein(LDL),blood uric acid(UA),left ventricular end-diastolic inner diameter(LVEDD)and left ventricular ejection fraction(LVEF)between CHD group and control group(all P<0.05).Compared with the control group,the levels of APN and Ghrelin in CHD group were significantly decreased(all P<0.05).Compared with the control group,PAG in CHD group was significantly increased(P<0.05).Pearson correlation analysis showed that serum APN and Ghrelin levels were significantly negatively correlated with PAG in CHD patients(r=-0.792,-0.578,all P<0.05).Among the 83 CHD patients,26 had MACE.Compared with the patients without MACE,there were significant differences in HDL、LVEDD、LVEF、APN and Ghrelin between the two groups(all P<0.05).Logistic regression analysis showed that HDL、LVEF、APN and Ghrelin were protective factors for MACE occurrence(all P<0.05).Conclusion:The serum levels of APN and Ghrelin levels in elderly CHD patients are significantly reduced,and are closely related to platelet aggregation rate and prognosis.Low levels of APN and Ghrelin can reflect the risk of MACE in CHD patients to a certain extent.

参考文献/References:

[1] KATTA N,LOETHEN T,LAVIE C J,et al.Obesity and coronary heart disease:Epidemiology,pathology,and coronary artery imaging[J].Curr Probl Cardiol,2021,46(3):100655.
[2] ILARDI F,GARGIULO G,PAOLILLO R,et al.Impact of chronic kidney disease on platelet aggregation in patients with acute coronary syndrome[J].Journal of Cardiovascular Medicine,2020,21(9):660-666.
[3] 杨延洁,周慧龙.不同双抗血小板疗程对冠心病合并房颤PCI术后患者远期预后的影响[J].陕西医学杂志,2019,48(12):1653-1656.
[4] SHAYA G E,LEUCKER T M,JONES S R,et al.Coronary heart disease risk:Low-density lipoprotein and beyond[J].Trends Cardiovasc Med,2022,32(4):181-194.
[5] CHOI H M,DOSS H M,KIM K S.Multifaceted physiological roles of adiponectin in inflammation and diseases[J].Int J Mol Sci,2020,21(4):1219.
[6] LU Y,MA Y C,WANG R H,et al.Adiponectin inhibits vascular smooth muscle cell calcification induced by beta-glycerophosphate through JAK2/STAT3 signaling pathway[J].Journal of Biosciences,2019,44(4):1-12.
[7] 张显敏,梁琳.血浆脂联素、脂蛋白相关磷脂酶A2检测联合颈动脉超声检查对冠状动脉易损斑块的诊断价值[J].陕西医学杂志,2022,51(6):713-716.
[8] SULLIVAN R,RANDHAWA V,LALONDE T,et al.Regional differences in the ghrelin-growth hormone secretagogue receptor signaling system in human heart disease[J].CJC Open,2020,3(2):182-194.
[9] YUAN M J,LI W,ZHONG P.Research progress of ghrelin on cardiovascular disease[J].Bioscience Reports,2021,41(1):1-8.
[10] 中华医学会老年医学分会高龄老年冠心病诊治中国专家.高龄老年冠心病诊治中国专家共识[J].中华老年医学杂志,2016,35(7):683-691.
[11] CARSON E,HEMENWAY A N.Recent evidence examining efficacy and safety of aspirin for primary cardiovascular disease prevention[J].Annals of Pharmacotherapy,2019,53(7):738-745.
[12] WINIEWSKI A,FILIPSKA K,SIKORA J,et al.Aspirin resistance affects medium-term recurrent vascular events after cerebrovascular incidents:A three-year follow-up study[J].Brain Sciences,2020,10(3):179-188.
[13] 罗超,任琳子,马妮娜,等.血小板/总胆红素与欧洲心脏手术风险评估系统Ⅱ评分对冠心病患者经皮冠状动脉介入治疗术后主要不良心脑血管事件发生的预测效能[J].陕西医学杂志,2023,52(3):313-316,320.
[14] STRAUB L G,SCHERER P E.Metabolic messengers:Adiponectin[J].Nat Metab,2019,1(3):334-339.
[15] ZHAO S,KUSMINSKI C M,SCHERER P E.Adiponectin,leptin and cardiovascular disorders[J].Circ Res,2021,128(1):136-149.
[16] LUN A,MARY S C.Adiponectin and coronary artery disease risk:A bi-directional mendelian randomization study[J].International Journal of Cardiology,2018,268(20):222-226.
[17] GUELLI M,CORREA T L.Relationship between adiponectin and myocardial infarction among diabetic patients[J].American Heart Journal,2021,242(11):157-158.
[18] JIANG K,XUE C,CUI J,et al.Correlations of adiponectin gene polymorphism and serum adiponectin level with coronary artery disease and its lesion degree[J].Minerva Medica,2021,112(3):1-10.
[19] 于豆豆,董国财,杨汉麒,等.成纤维细胞生长因子21、脂联素、游离脂肪酸与冠心病严重程度及不良预后的相关性研究[J].国际检验医学杂志,2021,42(8):986-990.
[20] Tokudome T,Kangawa K.Physiological significance of ghrelin in the cardiovascular system[J].Proc Jpn Aca Ser B,Phys Biol Sci,2019,95(8):459-467.
[21] YUAN M J,LI W,ZHONG P.Research progress of ghrelin on cardiovascular disease[J].Biosci Rep,2021,41(1):bsr20203387.
[22] GRUZDEVA O V,BORODKINA D A,BELIK E V,et al.Ghrelin physiology and pathophysiology:Focus on the cardiovascular system[J].Kardiologiia,2019,59(3):60-67.
[23] WU C R,YANG Q Y,CHEN Q W,et al.Ghrelin attenuate cerebral microvascular leakage by regulating inflammation and apoptosis potentially via a p38 MAPK-JNK dependent pathway[J].Biochemical and Biophysical Research Communications,2021,552(11):37-43.
[24] NAMAZI G,SALAMI R,POURFARZAM M,et al.Association of the serum apelin,but not ghrelin,with the presence and severity of coronary artery disease[J].Indian Heart Journal,2021,73(2):214-217.
[25] 杜艳梅, 田展松, 李红, 等. ApoE 基因多态性、Hcy与2型糖尿病患者发生冠状动脉粥样硬化性心脏病的相关性研究[J]. 空军军医大学学报, 2023, 44(8): 717-720.
[26] 程光慧,贾慧宇,任建新,等.老年冠心病患者心功能水平及主要心脏不良事件与Ghrelin水平相关性分析[J].现代中西医结合杂志,2018,27(32):3572-3575.

相似文献/References:

[1]李艳艳,贾 伟△.24h动态心电图在2型糖尿病合并冠心病患者心律诊断中的价值分析[J].陕西医学杂志,2019,(1):61.
[2]汤克虎,高峻峰,任尽平.药物涂层球囊在糖尿病患者冠状动脉小血管病变治疗中的应用研究*[J].陕西医学杂志,2019,(4):432.
[3]马党捐 ,康彦智 ,柴茂林.64排128层螺旋CT冠状动脉成像在冠心病患者诊断中的价值研究*[J].陕西医学杂志,2019,(5):624.
　MA Dangjuan,KANG Yanzhi,CHAI Maolin..Value analysis of 64rows 128slice spiral CT coronary angiography in the diagnosis of patients with coronary heart disease[J].,2019,(7):624.
[4]沈 琳,马文苑.曲美他嗪联合氯吡格雷治疗冠心病心绞痛疗效及对患者心电图、血清超敏C反应蛋白和五聚素3的影响[J].陕西医学杂志,2019,(6):794.
　SHEN Lin,MA Wenyuan.ElectrocardiogramRoom,Therapeutic Effect ofTrimetazidine Combined with Clopidogrel on Angina Pectoris and its Hs-CRP[J].,2019,(7):794.
[5]杨延洁,周慧龙△.不同双抗血小板疗程对冠心病合并房颤PCI术后患者远期预后的影响*[J].陕西医学杂志,2019,(12):1653.
[6]魏 勇,梁 琪,左浩源,等.右美托咪定预处理对冠心病非心脏手术患者心肌的保护作用*[J].陕西医学杂志,2019,(12):1706.
　WEI Yong,LIANG Qi,ZUO Haoyuan,et al.Protective effect of dexmedetomidine preconditioning on myocardium in patients with coronary heart disease undergoing nonheart surgery[J].,2019,(7):1706.
[7]刘玉珊.心外膜脂肪定量及可溶性血栓调节蛋白与冠心病病变程度相关性分析[J].陕西医学杂志,2020,49(1):44.
　LIU Yushan..Correlation between the distribution of epicardial adipose tissue and soluble thrombomodulin and the severity of coronary heart disease[J].,2020,49(7):44.
[8]赵 博,王银谦,王红燕.巨噬细胞移动抑制因子与冠心病关系Meta分析[J].陕西医学杂志,2020,49(1):125.
[9]王亚平,彭春艳,朱名安Δ.冠心病合并代谢综合征患者固醇调节元件结合蛋白表达水平与脂代谢指标相关性研究*[J].陕西医学杂志,2020,49(4):419.
　WANG Yaping,PENG Chunyan,ZHU Mingan..Correlation between the levels of SREBPs and the indicators of lipid metabolism in patients with coronary heart disease complicated with metabolic syndrome[J].,2020,49(7):419.
[10]南格利.冠心病颈动脉超声参数与斑块稳定性及炎症反应水平相关性分析[J].陕西医学杂志,2020,49(4):453.
　NAN Geli..Correlation between carotid ultrasound parameters and plaque stability and inflammatory response in patients with coronary heart disease[J].,2020,49(7):453.

备注/Memo

备注/Memo:
基金项目:河北省医学科学研究重点课题计划项目(20211799)
更新日期/Last Update: 2024-07-04